Skip to content

The Effect of Rivandi Syrup on Non-Alcoholic Fatty Liver

To Evaluate the Efficacy of Rivandi Syrup on Non-Alcoholic Fatty Liver Patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220529055009N1
Enrollment
50
Registered
2023-02-05
Start date
2022-08-06
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Alcoholic Fatty Liver. Fatty (change of) liver, not elsewhere classified

Interventions

Intervention 1: Intervention group: rhubarb syrup is prepared in the pharmacy laboratory of the Faculty of Traditional Medicine of Tehran University of Medical Sciences (Jalinian medicine) with the co

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Non Alcoholic Fatty Liver Patients

Exclusion criteria

Exclusion criteria: Diabetes, Hypertension, Familial Hyper Lipedema, Chronic Heart Disease Alcohol Use Pregnancy, Lactation

Design outcomes

Primary

MeasureTime frame
CAP (Controlled Attenuation Parameter) Index in Fibroscan. Timepoint: 0 and 3 Months. Method of measurement: Fibroscan Device.;LSM (Liver Stiffness Measurement) in Fibroscan. Timepoint: 0 and 3 Months. Method of measurement: Fibroscan Device.

Secondary

MeasureTime frame
Blood Serum Aspartate Transferase (AST). Timepoint: 0 and 3th months. Method of measurement: Blood Test.;Blood Test Alanine aminotransferase (ALT). Timepoint: 0 and 3th months. Method of measurement: Laboratory Blood Test.;Blood Test Alkaline phosphatase (ALP). Timepoint: 0 and 3th months. Method of measurement: Laboratory Blood Test.;Body Mass Index (BMI)= ratio of person's weight in kilograms and height in metres squared. Timepoint: 0 and 3th months. Method of measurement: Standard Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Rezaeizadeh

Tehran University of Medical Sciences

rezaeizadeh@sina.tums.ac.ir+98 21 8897 4535

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026